Epilepsy due to neurocysticercosis: analysis of 203 patients.
about
Antiepileptic drugs for seizure control in people with neurocysticercosisDrugs for seizure control in people with neurocysticercosisCurrent consensus guidelines for treatment of neurocysticercosisMagnitude of the disease burden from neurocysticercosis in a developing countryNeurocysticercosis: a reviewTaenia solium cysticercosisConservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and reviewFrom seizures to epilepsy and its substrates: neurocysticercosisUnder seize: neurocysticercosis in an immigrant woman and review of a growing neglected diseaseProposed diagnostic criteria for neurocysticercosisEdema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment.Neurocysticercosis.Time trend of neurocysticercosis in children with seizures in a tertiary hospital of western Nepal.The characteristics of epilepsy in a largely untreated population in rural Ecuador.Epidemiology of the epilepsies.Neurocysticercosis and epilepsy in developing countries.A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approachesCalcific neurocysticercosis and epileptogenesis.Treatment of neurocysticercosis: current status and future research needsChildhood epilepsy due to neurocysticercosis: a comparative study.Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Substance P causes seizures in neurocysticercosis.Pediatric epilepsy -- an Indian perspective.Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological featuresImmunodiagnosis of neurocysticercosis: ways to focus on the challengeDiagnosis and treatment of neurocysticercosis.Transient cortical blindness as a manifestation of solitary cysticercus granuloma.Parasitic central nervous system infections in immunocompromised hostsActive epilepsy as indicator of neurocysticercosis in rural northwest India.Neurologic parasitic infections in immigrants and travelers.Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study.Epilepsy and neurocysticercosis in sub-Saharan Africa.A pain in the…ventricle.Epilepsy: Indian perspective.Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and managementCysticercosis of the central nervous system: how should it be managed?Clinical characteristics, risk factors and pre-surgical evaluation of post-infectious epilepsy.Diagnostic criteria for neurocysticercosis, revisited.Current status and future perspectives on the medical treatment of neurocysticercosis.Clinical management of neurocysticercosis.
P2860
Q24186541-F99139C7-6D26-41A2-89C1-8362ECD3E0C0Q24236342-9BD55283-EABF-4A60-9936-CA1D52A51B5EQ24535667-B11ADCF5-E815-46CE-A0B2-A9464A8CE38EQ24599487-E4816DE7-D529-4986-B7C1-A5AD09057B45Q24606075-8638B318-0D86-4DBF-9803-7592BC0D2BF1Q24630431-B3FF5DDB-D594-4CE2-80AF-E0E293A3E6B7Q27015925-911E2FD8-E891-486E-BD79-9437A1A63EC6Q27028097-BC37BF23-9309-4D97-BC43-CC263894CB3FQ28082720-F1452969-2108-4C4F-982D-0556E54663E3Q28345027-FCD4849C-AC14-47F1-B064-F020884EB48FQ30583166-DF44B408-5326-42ED-86AA-36962BFD6589Q31983351-E788C92E-B478-4E76-8FD7-2D198B33474AQ33714019-8236A304-0EFB-4975-8CDB-DE8AD691B59BQ33732220-86400880-EA88-49BF-AD97-F729F514FAF8Q33735546-9552AC6B-C683-4198-BED4-E9D7CDCB58E7Q33822596-B11F3B10-7F42-4334-8D09-5F6088B965A0Q33930522-24B8698F-4875-4931-B380-7A6F87326D42Q34030036-1873079D-B4B3-42F9-BC92-4EA7D6197CAAQ34071278-48556782-EFBF-48EA-940B-1BDB5258C304Q34117103-4B64C67B-B8F8-4F88-92FC-95D21436CA3AQ34150372-B9C4000F-24CF-4CCC-B905-7D09A151B0D8Q34162248-2FA0CD45-6729-46EC-B17D-93A485BB7B36Q34416385-84D5835A-A199-4C3C-AAA4-81668E9A9D95Q35186817-5CB11D8A-23AB-4C00-86FD-FA61D48833CBQ35498241-A097A452-AB1F-485D-B89D-27F080268945Q35953198-A5D26735-459C-486E-92C0-D216465FBD89Q35979512-8DC5D92F-F7DC-4496-8780-5FFE302B9BA1Q36095864-E9B2887C-38F6-4E4F-876D-64F6A19B0BFCQ36168770-FF151FAA-013B-4DC0-A8AD-B5DB323A8DC9Q36415869-4E2C5531-3CA6-4379-8308-E867229CBB07Q37051218-8860A79A-0953-4626-B9A6-ED82252077BDQ37633387-011E27DF-1264-4770-8DCC-06CFD15BD76EQ37724365-14A03869-960F-43D7-8E14-4B04A87BEB82Q37725952-A162D1FA-5521-4412-83A9-2A2D27956F84Q37733228-303C98A4-A0FE-4629-B662-8AD72C08AF86Q37905499-76CF436D-D9EE-48E1-8528-07FB2F836A27Q38040172-BC2C8215-25F0-4B3B-8FA4-4D856004DFE7Q38069636-2F2132C6-4A89-45A5-B05B-743DF05C59ADQ38069637-931B29AE-56DA-4F1C-8085-5D3C2FF0F378Q38189498-F40B7185-10BE-40DA-9944-68A12A77B206
P2860
Epilepsy due to neurocysticercosis: analysis of 203 patients.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Epilepsy due to neurocysticercosis: analysis of 203 patients.
@en
Epilepsy due to neurocysticercosis: analysis of 203 patients.
@nl
type
label
Epilepsy due to neurocysticercosis: analysis of 203 patients.
@en
Epilepsy due to neurocysticercosis: analysis of 203 patients.
@nl
prefLabel
Epilepsy due to neurocysticercosis: analysis of 203 patients.
@en
Epilepsy due to neurocysticercosis: analysis of 203 patients.
@nl
P2093
P356
P1433
P1476
Epilepsy due to neurocysticercosis: analysis of 203 patients.
@en
P2093
P304
P356
10.1212/WNL.42.2.389
P407
P577
1992-02-01T00:00:00Z